Abstract:Liver cancer is the third most deadly cancers in the world. Unfortunately, there is no effective treatment. One of the major problems is that most cancers are diagnosed in the later stage, when surgical resection is not feasible. Thus, accurate early diagnosis would significantly improve the clinical outcome of liver cancer. Currently, there are no effective molecular probes to recognize biomarkers that are specific for liver cancer. The objective of our current study is to identify liver cancer cell-specific molecular probes that could be used for liver cancer recognition and diagnosis. We applied a newly developed cell-SELEX (Systematic Evolution of Ligands by EXponential enrichment) method for the generation of molecular probes for specific recognition of liver cancer cells. The cell-SELEX uses whole live cells as targets to select aptamers (designed DNA/RNA) for cell recognition. In generating aptamers for liver cancer recognition, two liver cell lines were used: a liver cancer cell line BNL 1ME A.7R.1 (MEAR) and a noncancer cell line, BNL CL.2 (BNL). Both cell lines were originally derived from Balb/cJ mice. Through multiple rounds of selection using BNL as a control, we have identified a panel of aptamers that specifically recognize the cancer cell line MEAR with Kd in the nanomolar range. We have also demonstrated that some of the selective aptamers could specifically bind liver cancer cells in a mouse model. There are two major new results (compared with our reported cell-SELEX methodology) in addition to the generation of aptamers specifically for liver cancer. The first one is that our current study demonstrates that cell-based aptamer selection can select specific aptamers for multiple cell lines, even for two cell lines with minor differences (MEAR cell is derived from BNL by chemical inducement); and the second result is that cell-SELEX can be used for adhesive cells and thus open the door for solid tumor selection and investigation. The newly generated cancer-specific aptamers hold great promise as molecular probes for cancer early diagnosis and basic mechanism studies.

Whole cell-SELEX aptamers for fluorescence staining of frozen hepatocellular carcinoma tissues

Whole Cell-Selex Aptamers For Highly Specific Fluorescence Molecular Imaging Of Carcinomas In Vivo

Hepatocellular Carcinoma Detection by Cell Sensor Based on Anti-GPC3 Single-Chain Variable Fragment

Identification of Liver Cancer-Specific Aptamers Using Whole Live Cells.

Screening and application of aptamers as fluorescent biosensors for selective and sensitive detection of hepatocellular carcinoma and in vivo targeted delivery studies

Molecular Recognition of Human Liver Cancer Cells Using DNA Aptamers Generated Via Cell-SELEX

In Vivo Fluorescence Imaging of Tumors Using Molecular Aptamers Generated by Cell-Selex

Diagnosis Applications of New Hepatoma Carcinoma Cell Aptamers in Vitro

Fluorescent quantum dot-labeled aptamer bioprobes specifically targeting mouse liver cancer cells.

The aptamers generated from HepG2 cells

Identification of a New DNA Aptamer by Tissue-SELEX for Cancer Recognition and Imaging

An 'activatable' aptamer-based fluorescence probe for the detection of HepG2 cells.

Glypican-3-targeted precision diagnosis of hepatocellular carcinoma on clinical sections with a supramolecular 2D imaging probe.

Metastatic Cancer Cell and Tissue-Specific Fluorescence Imaging Using a New DNA Aptamer Developed by Cell-SELEX

Hexaphenyl-1,3-butadiene derivative: a novel "turn-on" rapid fluorescent probe for intraoperative pathological diagnosis of hepatocellular carcinoma

In Vivo Fluorescence Imaging of Hepatocellular Carcinoma Using a Novel GPC3-specific Aptamer Probe

Immuno-fluorescence Imaging of Hepatocellular Carcinoma Cells with ZnSe:Mn/ZnSe-IgG Probes

Selection of Aptamers for Human Hepatocellular Carcinoma with High Specificity

A Space-Dependent 'Enzyme-Substrate' Type Probe based on 'Carboxylesterase-Amide Group' for Ultrafast Fluorescent Imaging Orthotopic Hepatocellular Carcinoma

Using Dna Aptamer Probe for Immunostaining of Cancer Frozen Tissues

Au@SiO2@CuInS2–ZnS/Anti-AFP Fluorescent Probe Improves HCC Cell Labeling